2022
Exposome and Trans-syndromal Developmental Trajectories Toward Psychosis
Barzilay R, Pries L, Moore T, Gur R, van Os J, Rutten B, Guloksuz S. Exposome and Trans-syndromal Developmental Trajectories Toward Psychosis. Biological Psychiatry Global Open Science 2022, 2: 197-205. PMID: 36325037, PMCID: PMC9616341, DOI: 10.1016/j.bpsgos.2022.05.001.Peer-Reviewed Original ResearchEnvironmental exposuresEarly life environmental exposuresNonspecific clinical presentationClinical presentationTrajectories of riskClinical settingPrenatal periodMental healthDevelopmental cohortGenetic factorsEarly childhoodYounger cohortsCategorical outcomesSensitive periodCohortDevelopmental disordersAdolescent psychopathology
2021
Clinical, Biochemical and Genetic Variables Associated With Metabolic Syndrome in Patients With Schizophrenia Spectrum Disorders Using Second-Generation Antipsychotics: A Systematic Review
Sneller M, de Boer N, Everaars S, Schuurmans M, Guloksuz S, Cahn W, Luykx J. Clinical, Biochemical and Genetic Variables Associated With Metabolic Syndrome in Patients With Schizophrenia Spectrum Disorders Using Second-Generation Antipsychotics: A Systematic Review. Frontiers In Psychiatry 2021, 12: 625935. PMID: 33868046, PMCID: PMC8044798, DOI: 10.3389/fpsyt.2021.625935.Peer-Reviewed Original ResearchSecond-generation antipsychoticsC-reactive proteinSchizophrenia spectrum disordersMetabolic syndromeCurrent BMIGenetic factorsHigher ageHigher white blood cell countSystematic reviewWhite blood cell countSevere mental illness experienceHigher baseline BMIRisk of MetS.Cardiovascular disease mortalityBlood cell countCross-sectional studyHigher current BMIMore studiesMental illness experienceSpectrum disorderSGA exposureBaseline BMICohort studyClinical factorsTobacco smoking